Hi all,
I'm a fairly new tech and I have a question regarding testing methods on patients that are actively on DARA. My hospital currently uses gel as its primary testing method. DARA patients, of course, are panreactive 1-2+ throughout both in the ABSC and the ABID panel. My current policy is to perform a DTT-treated screen and treat units if they need a transfusion. We provide K matched units and perform AHG XMs on treated RBCs. Many of these patients are surprise patients and there is frustration from providers when we tell them that the work up will take a few hours.
I never want to jeopardize patient safety, however, I'm wondering if there is a more efficient way to work up patients on DARA. Is it possible to repeat the ABSC in tube using both PEG and LISS? I have found that some PEG and LISS screens are negative. Would having 2 negative ABSCs in tube support that the reactivity in gel is interference from DARA?
@Bet'naSBB Thank you. This is what I think our workflow should be as well. I’ll consult with management.
